Droeser et al[13] have demonstrated that a high PD-L1 expression in MMR-proficient CRC is correlated with improved overall survival, while Dunne et al[17] have reported that PD-L1 expression is associated with a significantly better DFS in MMR-deficient patients. This evidence concerns the gene CD274 and colorectal carcinoma.